actinic keratosis
Dermatology · 2012–2014
4decisions
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| ingenol mebutate Treatment of solar (actinic) keratoses on the face and scalp as field therapy in adults. | Jul 2014 | Not recommended | input received |
| ingenol mebutate Field therapy for the treatment of solar keratoses of the face and scalp in patients who have had a previously diagnosed squamous cell carcinoma (SCC). | Nov 2013 | Not recommended | no section in document |
| ingenol mebutate Field therapy for the treatment of solar keratoses of the face and scalp in patients where topical fluorouracil (5-FU) is clinically inappropriate. | Nov 2012 | Not recommended | unclear |
| ingenol mebutate Field treatment of solar (actinic) keratoses of the face and scalp in patients where topical fluorouracil 5% is clinically inappropriate. | Nov 2012 | Not recommended | unclear |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.